Request for Public Comment: 60-Day Proposed Information Collection: Application for Participation in the IHS Scholarship Program, 45054-45055 [07-3895]
Download as PDF
<![CDATA[
45054
Federal Register / Vol. 72, No. 154 / Friday, August 10, 2007 / Notices
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
1482.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In the
Federal Register of December 13, 2006
(71 FR 74924), the agency announced
that the proposed information collection
had been submitted to OMB for review
and clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0530. The
approval expires on May 31, 2010. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.fda.gov/
ohrms/dockets.
Request for Public Comment: 60-Day
Proposed Information Collection:
Application for Participation in the IHS
Scholarship Program
SUPPLEMENTARY INFORMATION:
Dated: August 6, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–15614 Filed 8–9–07; 8:45 am]
BILLING CODE 4160–01–S
Indian Health Service
Indian Health Service, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 which requires
60 days for public comment on
proposed information collection
projects, the Indian Health Service (IHS)
is publishing for comment a summary of
a proposed information collection to be
submitted to the Office of Management
and Budget (OMB) for review.
Proposed Collection: Title: 0917–
0006, ‘‘Application for Participation in
the IHS Scholarship Program.’’ Type of
Information Collection Request: Threeyear extension, without change of
currently approved information
collection, 0917–0006, ‘‘Application for
Participation in the IHS Scholarship
Program.’’ Form Number(s): IHS–856,
856–2 through 856–8, IHS–815, IHS–
816, IHS–817, IHS–818, D–02, F–02, F–
Number of
respondents
Data collection instruments(s)
Responses
per respondent
04, G–02, G–04, H–07, H–08, J–04, J–05,
K–03, K–04, and L–03. Reporting
formats are contained in an IHS
Scholarship Program application
booklet. Need and Use of Information
Collection: The IHS Scholarship Branch
needs this information for program
administration and uses the information
to solicit, process, and award IHS Pregraduate, Preparatory, and/or Health
Professions Scholarship grants and
monitor the academic performance of
awardees and to place awardees at
payback sites. The IHS Scholarship
Program is streamlining the application
to reduce the time needed by applicants
to complete and provide the
information. The IHS Scholarship
Program plans on using information
technology to make the application
electronically available on the internet.
Affected Public: Individuals, not-forprofit institutions and State, local or
tribal government. Type of Respondents:
Students pursuing health care
professions.
The table below provides: Types of
data collection instruments, Estimated
number of respondents, Number of
responses per respondent, Annual
number of responses, Average burden
hour per response, and Total annual
burden hour(s).
Total annual
response
Scholarship Application (IHS–856) ..............................
Checklist (856–2) .........................................................
Course Verification (856–3) .........................................
Faculty/Employer Application (856–4) .........................
Justification (856–5) .....................................................
Federal Debt (856–6) ...................................................
Job Experience (856–7) ...............................................
Accept/Decline (856–8) ................................................
Receipt of Application (815) ........................................
Address Change Notice (816) .....................................
Scholarship Program Agreement (817) .......................
Health Professions Contract (818) ..............................
Stipend Check (D–02) .................................................
Enrollment (F–02) ........................................................
Academic Problem/Change (F–04) .............................
Request Assistance (G–02) .........................................
Summer School (G–04) ...............................................
Placement (H–07) ........................................................
Graduation (H–08) .......................................................
Site Preference (J–04) .................................................
Travel Reimb (J–05) ....................................................
Status Report (K–03) ...................................................
Preferred Assignment (K–04) ......................................
Request of Deferment (L–03) ......................................
1500
1500
1500
1500
1500
1500
25
650
1500
25
850
650
100
1300
50
217
193
250
250
150
150
250
200
20
1
1
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1500
1500
1500
3000
1500
1500
25
650
1500
25
850
650
100
1300
50
217
193
250
250
150
150
250
200
20
Total ......................................................................
15,830
............................
........................
Burden hour
per response *
1.00 (60
0.13 (8
0.70 (42
0.83 (50
0.75 (45
0.13 (8
0.83 (50
0.13 (8
0.03 (2
0.02 (1
0.05 (3
0.05 (3
0.13 (8
0.13 (8
0.13 (8
0.13 (8
0.10 (6
0.18 (11
0.17 (10
0.13 (8
0.10 (6
0.25 (15
0.75 (45
0.13 (8
Annual
burden hours
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
min)
1500
195
1050
2490
1125
195
21
84
45
25
43
33
13
169
6
28
19
45
43
20
15
63
150
3
............................
7,380
sroberts on PROD1PC70 with PROPOSALS
* For ease of understanding, burden hours are also provided in actual minutes.
There are no Capital Costs, Operating
Costs, and/or Maintenance Costs to
report.
Request for Comments: Your written
comments and/or suggestions are
VerDate Aug<31>2005
16:37 Aug 09, 2007
Jkt 211001
invited on one or more of the following
points: (a) Whether the information
collection activity is necessary to carry
out an agency function; (b) whether the
agency processes the information
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
collected in a useful and timely fashion;
(c) the accuracy of public burden
estimate (the estimated amount of time
needed for individual respondents to
provide the requested information); (d)
E:\FR\FM\10AUN1.SGM
10AUN1
Federal Register / Vol. 72, No. 154 / Friday, August 10, 2007 / Notices
whether the methodology and
assumptions used to determine the
estimates are logical; (e) ways to
enhance the quality, utility, and clarity
of the information being collected; and
(f) ways to minimize the public burden
through the use of automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Send Comments and Requests for
Further Information: Send your written
comments, requests for more
information on the proposed collection,
or requests to obtain a copy of the data
collection instrument(s) and
instructions to: Mrs. Chris Rouleau, IHS
Reports Clearance Officer, 801
Thompson Ave., Suite 450, Rockville,
MD 20852–1601; call non-toll free (301)
443–5938; send via facsimile to (301)
443–2316; or send your e-mail requests,
comments, and return address to:
Christina.Rouleau@ihs.gov.
Comment Due Date: Your comments
regarding this information collection are
best assured of having full effect if
received within 60 days of the date of
this publication.
Dated: August 3, 2007.
Charles W. Grim,
Assistant Surgeon General, Director, Indian
Health Service.
[FR Doc. 07–3895 Filed 8–9–07; 8:45 am]
BILLING CODE 4165–16–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
sroberts on PROD1PC70 with PROPOSALS
AGENCY:
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
VerDate Aug<31>2005
16:37 Aug 09, 2007
Jkt 211001
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Treatment for Cystic Fibrosis Cells and
Other Reduced ClØConductance Cells
Description of Technology: Cystic
fibrosis is the most common fatal
genetic disease among Caucasians. It is
caused by a defect in the cystic fibrosis
transmembrane regulator (CFTR)
protein. A normal CFTR transports
chloride ions across the membrane of
epithelial cells lining several organs in
the body such as the lungs and the
pancreas. The most debilitating
consequence of the defective CFTR
protein occurs in the lungs of cystic
fibrosis patients, where insufficient
chloride transport prevents water from
exiting epithelial cells. This causes the
lungs to produce abnormally thick,
sticky mucus that clogs the airways and
leads to fatal lung infections. Currently
there is no cure for the disease. Present
treatments result in undesired side
effects such as cardiac, renal, and/or
central nervous system tissue.
The NIH has developed a method of
identifying cystic fibrosis
transmembrane regulator binding
compounds for treating cells having a
reduced Cl¥conductance, such as
cystic fibrosis cells. It has also identified
a compound, 1,3-Diallyl-8cyclohexylxanthine (DAX), for potential
treatment of cystic fibrosis. Because
DAX has specificity in target areas of
activity, treatment with this compound
can potentially prevent all of the
complications of cystic fibrosis
including the production of abnormal
mucus and without undesired side
effects. DAX is active in extremely low
concentrations.
Applications: Diagnostic; Therapeutic
agent for the treatment of cells having a
reduced Cl¥conductance.
Market: This is intended for cystic
fibrosis or other reduced
Cl¥conductance cells; Approximately
70,000 children and young adults
worldwide, including 30,000 in the U.S.
and 30,000 in Europe.
Development Status: Dr. Pollard has
performed pre-clinical testing.
Inventors: Dr. Harvey B. Pollard and
Dr. Kenneth A. Jacobson (NIDDK).
Publications:
1. N Arispe et al. ‘‘Direct activation of
cystic fibrosis transmembrane
conductance regulator channels by 8–
cyclopentyl–1,3–dipropylxanthine
(CPX) and 1,3–diallyl–8–
cyclohexylxanthine (DAX),’’ J Biol
Chem. 1998 Mar 6;273(10):5727–5734.
2. KA Jacobson, C Guay-Broder, PJM
van Galen, C Gallo-Rodriguez, N
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
45055
Melman, O Eidelman, HB Pollard.
‘‘Stimulation by alkylxanthines of
chloride efflux in CFPAC-cells does not
involve A1-adenosine receptors,’’
Biochemistry, 1995 Jul 18;34(28):9088–
9094.
Patent Status:
U.S. Patent No. 5,877,179 issued 02
Mar 1999 (HHS Reference No. E–138–
1992/1–US–01). This patent is for
identifying binding compounds and
composition of matter.
U.S. Patent No. 6,083,954 issued 04
Jul 2000 (HHS Reference No. E–138–
1992/1–US–02). This patent is for
treating CF.
Foreign patent rights available.
Licensing Status: Available for
exclusive or non-exclusive licensing.
Licensing Contact: Catherine A.
Wendelken; 301/435–5282;
wendelkenc@od.nih.gov.
Dated: August 3, 2007.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E7–15622 Filed 8–9–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Research Program Project on Hypertension in
Youth.
Date: September 7, 2007.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Washington, 1515
Rhode Island Ave., NW., Washington, DC
20005.
Contact Person: Holly Patton, PhD,
Scientific Review Administrator, Review
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 72, Number 154 (Friday, August 10, 2007)]
[Notices]
[Pages 45054-45055]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-3895]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60-Day Proposed Information
Collection: Application for Participation in the IHS Scholarship
Program
AGENCY: Indian Health Service, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 which requires 60 days for public comment on
proposed information collection projects, the Indian Health Service
(IHS) is publishing for comment a summary of a proposed information
collection to be submitted to the Office of Management and Budget (OMB)
for review.
Proposed Collection: Title: 0917-0006, ``Application for
Participation in the IHS Scholarship Program.'' Type of Information
Collection Request: Three-year extension, without change of currently
approved information collection, 0917-0006, ``Application for
Participation in the IHS Scholarship Program.'' Form Number(s): IHS-
856, 856-2 through 856-8, IHS-815, IHS-816, IHS-817, IHS-818, D-02, F-
02, F-04, G-02, G-04, H-07, H-08, J-04, J-05, K-03, K-04, and L-03.
Reporting formats are contained in an IHS Scholarship Program
application booklet. Need and Use of Information Collection: The IHS
Scholarship Branch needs this information for program administration
and uses the information to solicit, process, and award IHS Pre-
graduate, Preparatory, and/or Health Professions Scholarship grants and
monitor the academic performance of awardees and to place awardees at
payback sites. The IHS Scholarship Program is streamlining the
application to reduce the time needed by applicants to complete and
provide the information. The IHS Scholarship Program plans on using
information technology to make the application electronically available
on the internet. Affected Public: Individuals, not-for-profit
institutions and State, local or tribal government. Type of
Respondents: Students pursuing health care professions.
The table below provides: Types of data collection instruments,
Estimated number of respondents, Number of responses per respondent,
Annual number of responses, Average burden hour per response, and Total
annual burden hour(s).
----------------------------------------------------------------------------------------------------------------
Data collection Number of Responses per Total annual Burden hour per Annual burden
instruments(s) respondents respondent response response * hours
----------------------------------------------------------------------------------------------------------------
Scholarship Application (IHS- 1500 1 1500 1.00 (60 min) 1500
856).......................
Checklist (856-2)........... 1500 1 1500 0.13 (8 min) 195
Course Verification (856-3). 1500 1 1500 0.70 (42 min) 1050
Faculty/Employer Application 1500 2 3000 0.83 (50 min) 2490
(856-4)....................
Justification (856-5)....... 1500 1 1500 0.75 (45 min) 1125
Federal Debt (856-6)........ 1500 1 1500 0.13 (8 min) 195
Job Experience (856-7)...... 25 1 25 0.83 (50 min) 21
Accept/Decline (856-8)...... 650 1 650 0.13 (8 min) 84
Receipt of Application (815) 1500 1 1500 0.03 (2 min) 45
Address Change Notice (816). 25 1 25 0.02 (1 min) 25
Scholarship Program 850 1 850 0.05 (3 min) 43
Agreement (817)............
Health Professions Contract 650 1 650 0.05 (3 min) 33
(818)......................
Stipend Check (D-02)........ 100 1 100 0.13 (8 min) 13
Enrollment (F-02)........... 1300 1 1300 0.13 (8 min) 169
Academic Problem/Change (F- 50 1 50 0.13 (8 min) 6
04)........................
Request Assistance (G-02)... 217 1 217 0.13 (8 min) 28
Summer School (G-04)........ 193 1 193 0.10 (6 min) 19
Placement (H-07)............ 250 1 250 0.18 (11 min) 45
Graduation (H-08)........... 250 1 250 0.17 (10 min) 43
Site Preference (J-04)...... 150 1 150 0.13 (8 min) 20
Travel Reimb (J-05)......... 150 1 150 0.10 (6 min) 15
Status Report (K-03)........ 250 1 250 0.25 (15 min) 63
Preferred Assignment (K-04). 200 1 200 0.75 (45 min) 150
Request of Deferment (L-03). 20 1 20 0.13 (8 min) 3
-----------------------------------------------------------------------------------
Total................... 15,830 ................ .............. ................ 7,380
----------------------------------------------------------------------------------------------------------------
* For ease of understanding, burden hours are also provided in actual minutes.
There are no Capital Costs, Operating Costs, and/or Maintenance
Costs to report.
Request for Comments: Your written comments and/or suggestions are
invited on one or more of the following points: (a) Whether the
information collection activity is necessary to carry out an agency
function; (b) whether the agency processes the information collected in
a useful and timely fashion; (c) the accuracy of public burden estimate
(the estimated amount of time needed for individual respondents to
provide the requested information); (d)
[[Page 45055]]
whether the methodology and assumptions used to determine the estimates
are logical; (e) ways to enhance the quality, utility, and clarity of
the information being collected; and (f) ways to minimize the public
burden through the use of automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
Send Comments and Requests for Further Information: Send your
written comments, requests for more information on the proposed
collection, or requests to obtain a copy of the data collection
instrument(s) and instructions to: Mrs. Chris Rouleau, IHS Reports
Clearance Officer, 801 Thompson Ave., Suite 450, Rockville, MD 20852-
1601; call non-toll free (301) 443-5938; send via facsimile to (301)
443-2316; or send your e-mail requests, comments, and return address
to: Christina.Rouleau@ihs.gov.
Comment Due Date: Your comments regarding this information
collection are best assured of having full effect if received within 60
days of the date of this publication.
Dated: August 3, 2007.
Charles W. Grim,
Assistant Surgeon General, Director, Indian Health Service.
[FR Doc. 07-3895 Filed 8-9-07; 8:45 am]
BILLING CODE 4165-16-M
